BCV
EDIT icon

Banque Cantonale Vaudoise’s Editas Medicine EDIT Stock Holding History

Banque Cantonale Vaudoise’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,925
Closed -$23K – 1247
2022
Q2 		$23K Buy
1,925
+200
+12% +$2.68K ﹤0.01% 1109
2022
Q1 		$33K Hold
1,725
– – ﹤0.01% 1097
2021
Q4 		$46K Hold
1,725
– – ﹤0.01% 1084
2021
Q3 		$71K Buy
1,725
+225
+15% +$12.3K ﹤0.01% 1004
2021
Q2 		$69K Buy
1,500
+500
+50% +$18.5K ﹤0.01% 1012
2021
Q1 		$42K Hold
1,000
– – ﹤0.01% 1011
2020
Q4 		$70K Hold
1,000
– – ﹤0.01% 899
2020
Q3 		$28K Buy
+1,000
New +$32.6K ﹤0.01% 953

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Banque Cantonale Vaudoise's EDIT Position: Q3 2022 in Review

Banque Cantonale Vaudoise sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 1,925 shares — an estimated $23K sold.

Banque Cantonale Vaudoise first reported a position in EDIT in Q3 2020 and held it in 8 quarters. The position peaked at $71K in Q3 2021. 264 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

  • Banque Cantonale Vaudoise reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,925 Editas Medicine shares in Q3 2022, an estimated $23K.
  • Banque Cantonale Vaudoise first reported a position in Editas Medicine in Q3 2020 and held it in 8 quarters.
  • Banque Cantonale Vaudoise's Editas Medicine position peaked at $71K in Q3 2021.
  • 264 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2022, filed 17 Oct 2022.